tiprankstipranks
Idexx Laboratories (IDXX)
NASDAQ:IDXX

Idexx Laboratories (IDXX) Financial Statements

1,909 Followers

Idexx Laboratories Financial Overview

Idexx Laboratories's market cap is currently ―. The company's EPS TTM is $10.32; its P/E ratio is 46.16; Idexx Laboratories is scheduled to report earnings on August 6, 2024, and the estimated EPS forecast is $2.88. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 901.60M$ 915.53M$ 943.63M$ 900.20M$ 828.57M
Gross Profit$ 526.17M$ 737.00M$ 943.63M$ 542.97M$ 484.93M
EBIT-$ 276.54M$ 296.47M$ 280.81M$ 226.53M
EBITDA-$ 305.52M$ 324.33M$ 309.15M$ 255.25M
Net Income Common Stockholders$ 194.52M$ 212.23M$ 224.24M$ 214.05M$ 172.21M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 453.93M$ 331.70M$ 132.84M$ 111.37M$ 112.55M
Total Assets$ 3.26B$ 3.09B$ 2.87B$ 2.81B$ 2.75B
Total Debt$ 1.05B$ 1.12B$ 1.13B$ 1.30B$ 1.45B
Net Debt$ 593.62M$ 788.58M$ 1.00B$ 1.19B$ 1.34B
Total Liabilities$ 1.78B$ 1.79B$ 1.78B$ 1.97B$ 2.75B
Stockholders Equity$ 1.48B$ 1.30B$ 1.09B$ 841.10M$ 608.74M
Cash Flow-
Free Cash Flow-$ 238.34M$ 172.84M$ 144.40M$ 124.20M
Operating Cash Flow$ 249.85M$ 272.43M$ 200.31M$ 183.91M$ 173.43M
Investing Cash Flow$ -30.43M$ -27.84M$ -27.47M$ -39.51M$ -49.23M
Financing Cash Flow$ -101.84M$ -43.04M$ -151.03M$ -146.08M$ -116.72M
Currency in USD

Idexx Laboratories Earnings and Revenue History

Idexx Laboratories Debt to Assets

Idexx Laboratories Cash Flow

Idexx Laboratories Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis